Estrogen and progesterone receptor mrna levels in primary breast cancer: Association with patient survival and other clinical and tumor features

The relative expression of estrogen receptor (ER) and progesterone receptor (PR) mRNA transcripts was measured in 71 primary breast‐cancer biopsies. ER and PR binding activity were estimated in parallel by the dextran‐coated‐charcoal method. There was a close correlation between the amount of ER mRNA and estradiol binding activity. Tumors from post‐menopausal patients contained higher levels of ER mRNA than those from pre‐menopausal patients. Northern‐blot analysis indicated the presence of a major band of 6.3 kb in all ER mRNA‐positive tumors. Some tumors showed, in addition, 3,7‐ and 2.4‐kb transcripts. PR binding activity and overall PR mRNA levels correlated moderately. PR mRNA and ER mRNA were associated. Four PR mRNA species with estimated sizes of 11.4, 4.5, 3.7 and 2.5 kb were detected in 14% of the PR mRNA‐positive tumors. The 3.7‐kb transcript was detected to varying degrees in all PR mRNA‐positive biopsies, accompanied in some tumors by the 2.5‐kb species. ER and PR mRNA levels < 50 pg/5 μg total RNA correlated with prolonged survival of the patients. In addition, high ER mRNA levels were associated with absence of necrosis and vascular invasion together with absence or minimal level of tumor lymphocytic infiltration, but not with age, clinical stage, tumor size or overexpression of c‐myc or c‐erbB‐2 mRNA. PR mRNA was not statistically associated with any of the above clinicopathological features. A bivariate analysis showed that both ER and PR mRNA levels were able to predict overall survival independently of the lymph‐node status. © 1994 Wiley‐Liss, Inc.

[1]  W. McGuire,et al.  How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer , 1993, Cancer.

[2]  M. Nagai,et al.  Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors. , 1993, Oncology.

[3]  K. Horwitz,et al.  5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. , 1990, Molecular endocrinology.

[4]  A. Maggi,et al.  Regulation of progesterone receptor gene expression. , 1990, Cancer research.

[5]  Helmut Dotzlaw,et al.  Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. , 1990, Cancer research.

[6]  P Chambon,et al.  Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. , 1990, The EMBO journal.

[7]  R. Brentani,et al.  Independent prognostic value of laminin receptor expression in breast cancer survival. , 1990, Cancer research.

[8]  G. Contesso,et al.  A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. , 1989, Oncogene.

[9]  L. Murphy,et al.  Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. , 1989, Molecular endocrinology.

[10]  W. Godolphin,et al.  Survival with breast cancer: the importance of estrogen receptor quantity. , 1989, European journal of cancer & clinical oncology.

[11]  P. Chambon,et al.  Regulation of the estrogen receptor in MCF-7 cells by estradiol. , 1988, Molecular endocrinology.

[12]  J. Henry,et al.  Measurement of oestrogen receptor mRNA levels in human breast tumours. , 1988, British Journal of Cancer.

[13]  J. Klijn,et al.  The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer , 1988, Cancer.

[14]  R. Coombes,et al.  Characterization of estrogen receptor messenger RNA in human breast cancer. , 1987, Cancer research.

[15]  B. Fisher,et al.  Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors , 1987, Cancer.

[16]  P. Chambon,et al.  Cloning of the human estrogen receptor cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Fujiyama,et al.  Steroid receptors in a group of Brazilian breast cancer patients , 1981, Journal of surgical oncology.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.